1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Apolipoprotein E genotypes and longevity across dementia disorders
(
- Contribution to journal › Article
- 2017
-
Mark
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
(
- Contribution to journal › Article
-
Mark
CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
(
- Contribution to journal › Article
-
Mark
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
(
- Contribution to journal › Article
- 2016
-
Mark
Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression
(
- Contribution to journal › Article
- 2015
-
Mark
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
(
- Contribution to journal › Article
- 2014
-
Mark
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.
(
- Contribution to journal › Article